Third Harmonic Bio to Participate in Upcoming Investor Conferences in November
| THRD Stock | USD 12.94 0.17 1.30% |
About 66% of Third Harmonic's investor base is looking to short. The analysis of the overall investor sentiment regarding Third Harmonic Bio suggests that many traders are alarmed. The current market sentiment, together with Third Harmonic's historical and current headlines, can help investors time the market. In addition, many technical investors use Third Harmonic Bio stock news signals to limit their universe of possible portfolio assets.
Third |
SAN FRANCISCO, Nov. 07, 2024 -- Third Harmonic Bio, Inc. , a clinical-stage biopharmaceutical company focused on advancing the next wave of medicine for dermal, respiratory, and gastrointestinal inflammatory diseases, today announced that management will participate in the following upcoming conferences Natalie Holles, Chief Executive Officer, will participate in a fireside chat at the Stifel 2024 Healthcare Conference on Tuesday, November 19, 2024, at 300 p.m. E
Read at finance.yahoo.com
 |
Third Harmonic Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Third Harmonic can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Third Harmonic Fundamental Analysis
We analyze Third Harmonic's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Third Harmonic using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Third Harmonic based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Earning
Price To Earning Comparative Analysis
Third Harmonic is currently under evaluation in price to earning category among its peers. Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Third Harmonic Bio Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Third Harmonic stock to make a market-neutral strategy. Peer analysis of Third Harmonic could also be used in its relative valuation, which is a method of valuing Third Harmonic by comparing valuation metrics with similar companies.
Peers
Third Harmonic Related Equities
| GLUE | Monte Rosa | 5.93 | ||||
| SNSE | Sensei Biotherapeutics | 5.66 | ||||
| NUVB | Nuvation Bio | 3.21 | ||||
| CGEM | Cullinan Oncology | 2.51 | ||||
| ACRV | Acrivon Therapeutics, | 2.31 | ||||
| RLYB | Rallybio Corp | 1.85 | ||||
| PMVP | Pmv Pharmaceuticals | 0.63 | ||||
| HOWL | Werewolf Therapeutics | 0.51 | ||||
| EWTX | Edgewise Therapeutics | 0.37 | ||||
| RVMD | Revolution Medicines | 0.09 | ||||
| ELYM | Eliem Therapeutics | 1.30 | ||||
| NXTC | NextCure | 2.50 | ||||
| PASG | Passage Bio | 10.67 |
Complementary Tools for Third Stock analysis
When running Third Harmonic's price analysis, check to measure Third Harmonic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Third Harmonic is operating at the current time. Most of Third Harmonic's value examination focuses on studying past and present price action to predict the probability of Third Harmonic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Third Harmonic's price. Additionally, you may evaluate how the addition of Third Harmonic to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |